Destiny Pharma shares fall amid XF-73 fending off MRSA in wounds
August 05 2024 - 4:50AM
Alliance News
Destiny Pharma PLC
on Monday announced positive data for its lead drug exeporfinium
chloride, known as XF-73, and to ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Sep 2024 to Oct 2024
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Oct 2023 to Oct 2024